GlassScriptPhysician profile
Samuel J Goss
NPI 1063443653
$2,328.58
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $92.42 · 2021: $473 · 2022: $626 · 2023: $809 · 2024: $24.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $430.80 | 2021-2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $265.70 | 2021-2023 | Verquvo, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $257.05 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $213.19 | 2019-2022 | |
| Amgen INC. | $192.16 | 2020-2023 | Repatha |
| Boston Scientific Corporation | $174.16 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $138.99 | 2022 | |
| Alnylam Pharmaceuticals INC. | $121.18 | 2022-2023 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $99.52 | 2021-2023 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $71.79 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $66.77 | 2023 | |
| Pfizer INC. | $44.22 | 2022-2023 | |
| Abbott Laboratories | $43.91 | 2022-2023 | Mitraclip |
| Abiomed | $34.85 | 2023 | Impella |
| Amarin Pharma, INC. | $34.73 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $34.25 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $25.98 | 2021 | |
| Medtronic Vascular, INC. | $25.48 | 2019 | |
| Siemens Medical Solutions USA, INC. | $24.91 | 2024 | Symbia_evo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.93 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.